Business
Press Release May 26 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Eugia Pharma receives USFDA Approval for Carboprost Tromethamine Injection USP 250 mcg/mL".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 26, 2023, titled \"Eugia Pharma receives USFDA Approval for Carboprost Tromethamine Injection USP 250 mcg/mL\". View Attachment","length":359,"tagName":"div"}]